Evidence map›Paper›PMID 28085911›Full record

ArticlePloS one2017

D-Dimer Use and Pulmonary Embolism Diagnosis in Emergency Units: Why Is There Such a Difference in Pulmonary Embolism Prevalence between the United States of America and Countries Outside USA?

Gilles Pernod, Jeffrey Caterino, Maxime Maignan, Cindy Tissier, Jeannine Kassis, John Lazarchick, DIET study group

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01221805 completednot on this map

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

TypeobservationalSponsorDiagnostica StagoRan2011 to 2016Enrolled2,040ConditionsDeep Venous Thrombosis, Pulmonary Embolism, D-dimer
NCT06480994 recruitingnot on this mapstarted 2022, after this paper: background citation

Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support With Fresh Plasma, on Any Patient With VTE Suspicion

Typeobservational_patient_registrySponsorDiagnostica Stago R&DRan2022 to 2027Enrolled1,836ConditionsVenous Thromboembolism, Pulmonary Embolism, Deep Vein ThrombosisArmsRoutine Assays on fresh plasma, New Clinical Decision Support on fresh plasma, New Clinical Decision Support on frozen plasma
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Diagnostic Validation of PERC and Resource Utilization in Suspected Acute Pulmonary Embolism: A Systematic Review and Meta-Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  2. Trial
  3. Trial
  4. Contemporary approaches to pulmonary embolism diagnosis: a clinical review.Clinical and experimental emergency medicine · 2024
    Article
  5. Article
  6. Evaluation of the "hemoptysis" item in clinical decision rules for the diagnosis of pulmonary embolism in the emergency department.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2022
    Article
  7. Proteomics in thrombosis research.Research and practice in thrombosis and haemostasis · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Gilles PernodDepartment of Vascular Medicine, Grenoble-Alpes University Hospital, Université Grenoble Alpes CNRS / TIMC-IMAG UMR 5525 / Themas, Grenoble, France.
Jeffrey CaterinoDepartment of Emergency Medicine, Ohio State University, Columbus (Ohio); United States of America.
Maxime MaignanDepartment of Emergency Medicine, Grenoble-Alpes University Hospital, Grenoble, France.
Cindy TissierDepartment of Emergency Medicine, University Hospital Dijon, Dijon, France.
Jeannine KassisDepartment of Hematology, Hopital Maisonneuve-Rosemont, University of Montreal, Montreal, Canada.
John LazarchickPathology and Laboratory Medicine, Medical University South Carolina, Charleston, United States of America.
DIET study group
Maison des Sciences sociales et des Humanités de Dijon · FRMedical University of South Carolina · USThe Ohio State University · USTranslational Innovation in Medicine and Complexity · FRUniversité de Montréal · CAUniversité Grenoble Alpes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAlthough diagnostic guidelines are similar, there is a huge difference in pulmonary embolism (PE) prevalence between the United States of America (US) and countries outside the USA (OUS) in the emergency care setting. In this study, we prospectively analyze patients' characteristics and differences in clinical care that may influence PE prevalence in different countries.

methodsAn international multicenter prospective diagnostic study was conducted in a standard-of-care setting. Consecutive outpatients presenting to the emergency unit and suspected for PE were managed using the Wells score, STA-Liatest® D-Dimers and imaging.

resultsThe prevalence of PE in the study was 7.9% in low and moderate risk patients. Among the 1060 patients with low or moderate pre-test probability (PTP), PE prevalence was four times higher in OUS (10.7%) than in the US (2.5%) (P < 0.0001). The mean number of imaging procedures performed for one new PE diagnosis was 3.3 in OUS vs 17 in the US (P < 0.001). Stopping investigation in the case of negative D-dimers (DD combined) with low/moderate PTP was more frequent in OUS (92.7%) than in the US (75.7%) (P < 0.01). Moreover, the use of imaging was much higher in the US (44.4% vs 19.2% in OUS) in the case of moderate PTP combined with negative DD.

conclusionDifferences between US and OUS PE prevalence in emergency setting might be explained by differences in patients' characteristics and mostly in care patterns. US physicians performed computed tomographic pulmonary angiography more often than in Europe in cases of low/moderate PTP combined with negative DD.

trial registrationClinicalTrials.gov NCT01221805.

Indexed as

AdolescentAdultAgedAged, 80 and overAngiographyBiomarkersCanadaEmergency Service, HospitalEuropeFemaleFibrin Fibrinogen Degradation ProductsHumansMaleMiddle AgedOutpatientsPrevalenceBiomarkersFibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID28085911
PMCPMC5234786
OpenAlexW2579074212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.